Perfil
Matthew D.
Dallas served as an Independent Director at Harvard Apparatus Regenerative Technology, Inc. from 2018 to 2020.
Prior to that, he was the Chief Financial Officer & Treasurer at CoLucid Pharmaceuticals, Inc. from 2015 to 2017 and the Treasurer, Chief Accounting Officer & VP-Finance at AVEO Pharmaceuticals, Inc. from 2011 to 2015.
He also served as the Chief Financial Officer at AVEO Pharmaceuticals, Inc. from 2017 to 2019.
Currently, he is the Chief Financial Officer & Senior Vice President at Zealand Pharma A, a position he has held since 2019.
Mr. Dallas received his undergraduate degree from the University of Tennessee.
Antiguos cargos conocidos de Matthew D. Dallas.
| Empresas | Cargo | Fin |
|---|---|---|
| ZEALAND PHARMA A/S | Director Financiero/CFO | 31/08/2022 |
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Director/Miembro de la Junta | 03/02/2020 |
| AVEO PHARMACEUTICALS, INC. | Director Financiero/CFO | 26/09/2019 |
| COLUCID PHARMACEUTICALS INC | Director Financiero/CFO | 01/03/2017 |
| AVEO PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 06/02/2015 |
Formación de Matthew D. Dallas.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
CoLucid Pharmaceuticals, Inc.
CoLucid Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Health Technology |
Harvard Apparatus Regenerative Technology, Inc.
Harvard Apparatus Regenerative Technology, Inc. Medical SpecialtiesHealth Technology Engages in the development and commercialization of medical devices | Health Technology |
University of Tennessee
University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
Zealand Pharma A/S
Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
- Bolsa de valores
- Insiders
- Matthew D. Dallas
















